Partner Headlines - ALKS

  1. Rayno Biobeat #4: Sector Shift Underway But What’s Next For Biotech? ...

    TalkMarkets
  2. Trump Triumphs

    TalkMarkets
  3. Biotech Bear Market Looking For Relief From Q3 Large Cap Growth

    TalkMarkets
  4. Biotech Stock Roundup: Clinical Holds Hit Inovio & Aduro, Vertex ...

    TalkMarkets
  5. Alkermes bounces back after disappointments as depression drug ...

    TalkMarkets
  6. Jefferies Sees 'Attractive Buying Opportunities' In Biotech

    TalkMarkets
  7. Has Gold Lost Its Glimmer?

    TalkMarkets
  8. Alkermes down after drug fails

    IBD
  9. Mid-Afternoon Market Update: Crude Oil Surges Over 4%; Alkermes ...

    Benzinga
  10. Alkermes Hits Two-Year Low On Depression Drug Failure

    IBD
  11. Mid-Day Market Update: US Stocks Turn Higher; Plexus Shares Gain ...

    Benzinga
  12. Mid-Morning Market Update: Markets Drop; Verizon Profit Tops ...

    Benzinga
  13. 10 Stocks Moving In Thursday's Pre-Market Session

    Benzinga
  14. AvalonBay Communities, Equinix, Jarden, Alkermes Approach 52-Week ...

    GuruFocus
  15. Alkermes Reports Achievement of Milestones for CNS Medicines ...

    Benzinga
  16. U.S.-Traded Eurozone Stocks React Mildly To ECB Vote

    IBD
  17. Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest ...

    Benzinga
  18. Non-Opioid Therapeutics And Significant Pain Treatments Make ...

    Benzinga
  19. Benzinga's Volume Movers

    Benzinga
  20. Morning Market Gainers

    Benzinga
  21. Underappreciated Leader Skips Over Equal-Weight In Double Upgrade

    Benzinga
  22. Benzinga's Top #PreMarket Gainers

    Benzinga
  23. Benzinga's M&A Chatter for Tuesday June 16, 2015

    Benzinga
  24. US Stock Futures Decline Ahead Of Housing Starts Report

    Benzinga
  25. Alkermes to Present Data From Late-Stage CNS Portfolio at Upcoming ...

    Benzinga
  26. Alkermes Reports Phase 3 Study Results for Aripiprazole Lauroxil ...

    Benzinga
  27. US Stock Futures Edge Lower; GDP Report In Focus

    Benzinga
  28. Alkermes to Present Clinical Data on ALKS 8700 at Annual Meeting ...

    Benzinga
  29. Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest ...

    Benzinga
  30. Benzinga's Top Initiations

    Benzinga
  31. Barclays Initiates Alkermes With Overweight

    Benzinga
  32. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga
  33. Stocks Mostly Higher: Time Warner Clears Buy Point

    IBD
  34. Why Citigroup Placed An $85 Price Target On Shares Of Alkermes

    Benzinga
  35. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  36. Alkermes pops to 15-year high

    IBD
  37. Alkermes Hits High On Schizophrenia Drug Results

    IBD
  38. Morning Market Gainers

    Benzinga
  39. Benzinga's Top #PreMarket Gainers

    Benzinga
  40. Benzinga's Volume Movers

    Benzinga
  41. 3 Biotech ETFs Rally On Merger News

    Benzinga
  42. Top 4 Stocks In The Drug Delivery Industry With The Highest Revenue

    Benzinga
  43. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga
  44. Alkermes Announces Completion Of Patient Enrollment In Phase ...

    Benzinga
  45. US Stock Futures Rise Ahead Of Economic Data

    Benzinga
  46. Morgan Stanley Sees EPS Below Consensus, Robust Pipeline For ...

    Benzinga
  47. Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest ...

    Benzinga
  48. Alkermes' drug passes trial

    IBD
  49. Market Wrap For April 8: Markets Bounce Higher As Earnings Season ...

    Benzinga
  50. Stocks Rise, Led By Tech Stocks, But Volume Fades

    IBD
  51. Mid-Afternoon Market Update: Markets Recover Slightly as Coal ...

    Benzinga
  52. Mid-Day Market Update: US Stocks Gain; Gigamon Shares Dip On ...

    Benzinga
  53. Alkermes' Schizophrenia Drug Passes Trial; Filing In Q3

    IBD
  54. Benzinga's Volume Movers

    Benzinga
  55. Mid-Morning Market Update: Markets Mixed; A. Schulman Lifts Profit ...

    Benzinga
  56. Morning Market Movers

    Benzinga
  57. Alkermes Announces Positive Topline Results From Pivotal Phase ...

    Benzinga
  58. Benzinga's Top Initiations

    Benzinga
  59. Nasdaq Back Above Water; Green Plains Jumps

    IBD
  60. LifeLock, YY Among 5 Stocks With Top Fundamentals

    IBD
  61. Stocks Fall In Higher Volume; Yandex, Twitter Drop

    IBD
  62. Stocks Weaken After Fed Minutes; Thor Rallies

    IBD
  63. Stocks End Short Week With Big Losses

    IBD
  64. Alkermes Announces Advances in Late-Stage CNS Pipeline

    Benzinga
  65. Alkermes Receives Notice of Allowance of US Patent for Novel ...

    Benzinga
  66. Ireland Home To Several Fast Growing Health Care Names

    IBD
  67. Alkermes Presents Data on Aripiprazole Lauroxil and ALKS 5461 ...

    Benzinga
  68. UPDATE: Citigroup Raises PT on Alkermes on Multiple Value Opportunities

    Benzinga
  69. Alkermes, FDA Agree on Deal for Elements of ALKS 5461 Development ...

    Benzinga
  70. Top 4 Stocks In The Drug Delivery Industry With The Highest Cash

    Benzinga
  71. Acceleron Pharma IPO Pops; Fate Therapeutics On Deck

    IBD
  72. Google, LKQ, Tesla: Stocks A Marsico Manager Likes

    IBD
  73. Stocks End Mixed In Light Trade; Green Mountain Spurts Ahead

    IBD
  74. Stocks Down Modestly; Alkermes Ramps Up

    IBD
  75. Alkermes

    IBD
  76. Stocks Up, Google At High; Dow Takes Out 14,000

    IBD
  77. Regeneron, Other Biomed Stocks Rebound On New Drugs

    IBD
  78. Alkermes

    IBD
  79. Stocks Slip As Fed Stands Pat; SodaStream Trims Gain

    IBD
  80. Alkermes Trades Tightly, Holds In Buying Range

    IBD
  81. UPDATE: Credit Suisse Initiates Alkermes at Neutral; Looking ...

    Benzinga
  82. Celgene Leads 6 Medical Stocks With Bolting RS Lines

    IBD
  83. Top 4 Stocks In The Drug Delivery Industry With The Highest EPS ...

    Benzinga
  84. Stocks Hold Modest Gains; MI Homes Hits Multiyear High

    IBD
  85. Alkermes In Buy Area After Breakout In Strong Volume

    IBD
  86. Stocks Pare Early Losses, End With Modest Declines

    IBD
  87. Alkermes Announces Notice of Allowance of USPTO Application for ...

    Benzinga
  88. Alkermes Announces Positive Results from Phase 1 Study of ALKS ...

    Benzinga
  89. Biotech Alkermes Sketches Imperfect Cup With Handle

    IBD
  90. Alkermes' Acquisition Proves To Be Game-Changer

    IBD
  91. Alkermes' Corporate Presentation to be Webcast at Two Upcoming ...

    Benzinga
  92. Dow Leads Market Higher As Volume Swells

    IBD
  93. Stocks Add To Gains; DaVita HealthCare Jumps

    IBD
  94. Alkermes Flies As Q2 Results, Guidance Beat Estimates

    IBD
  95. Alkermes' Breakout Falls Victim To Market Correction

    IBD
  96. Stocks Tumble On Disappointing Earnings Reports

    IBD
  97. Why Cisco, Google And Apple All Became Big Winners

    IBD
  98. Biotech Alkermes Attracting Flocks Of Top-Rated Funds

    IBD
  99. Biogen, Cubist and Alexion Not The Only Biomed Leaders

    IBD
  100. Alkermes In Buying Range Above Cup-Base Entry

    IBD
Trading Center